Subject: Invite to participate in a study regarding treating RA with methotrexate
Attention: Rheumatoid Arthritis Patient
MedSpan is a healthcare market research firm based in Chicago, IL. We are conducting a study with patients suffering from RA who are currently taking oral or injectable methotrexate. The goal of the study is to understand your perception of methotrexate.
If you are interested in participating, please either contact one of our recruiters below or go to the link to see if you qualify. Here is our link and code to utilize our on-line screening process:
Link: http://www.medspanresearch.com/surveychooser.asp
Code: RAPSC
Recruiters to call for screening process:
Shirley Konwent Diane Karija
Recruiter Recruiter
MedSpan MedSpan
P: 847.577.0631 P: 847.550.9146
F: 847.510.0440 F: 847.510.0440
E: skonwent@medspanresearch.com E: dkarija@medspanresearch.com


Hmm I wonder if their survey is for the Drug companies to sell yet more or finding out the truth from users for the FDA ?
I hope this site publishes Medspan's findings so we can scrutinize.